Sat, 21 Nov, 2026☀ Indore 26°C
Market closedSENSEX83,919.71▲ 2.30%NIFTY 5025,800.60▲ 2.27%BANK NIFTY64,635.20▲ 4.19%INDIA VIX17.32▲ 11.24%हिंदी में पढ़ें →All markets →
Stories
INDIA2 MIN READ

Ministry of Health Proposes Dedicated Wholesale Licensing Norms for Bulk Drugs

The Ministry of Health and Family Welfare has introduced draft amendments to establish separate licensing provisions specifically for the wholesale trade of active and inactive bulk substances.

60-SECOND SUMMARY · AI-ASSISTED
  • The Ministry of Health and Family Welfare proposed separate licensing norms for bulk drug wholesale trade.
  • New application form 19-BC and licence form 20-BC will replace the current common licensing system.
  • Existing licensees have a transition period of 12 months or until their retention period expires, whichever is later.
London, 11th July 2012. Ms Anuradha Gupta, Joint Secretary, Ministry of Health and Family Welfare, India speaking at the London Summit on Family Planning. India committed at the su
हिन्दी में पढ़ेंAI translation · may contain errors
🧒 Explain it simplyAI-written · same facts

The Ministry of Health and Family Welfare has put forward a draft framework to separate wholesale licensing requirements for bulk drugs from those governing finished pharmaceutical formulations. Currently, a single unified licence permits the wholesale distribution of both finished medications and bulk active or inactive substances. Under the newly proposed amendments to the Drugs Rules, 1945, authorities intend to create distinct application forms, designated as 19-BC, and corresponding licence forms, designated as 20-BC, exclusively for bulk drug wholesalers.

Regulatory Oversight and Compliance Timeline

According to an official statement, the initiative aims to enhance tracking and enforcement within the pharmaceutical distribution network, particularly regarding antimicrobial resistance and substances governed by the Narcotic Drugs and Psychotropic Substances Act, 1985. The updated framework will require wholesale operations involving bulk substances to function under the direct supervision of a competent person. Furthermore, the documentation will explicitly record the specific categories of bulk substances handled by each distributor.

Approval for the regulatory changes was previously secured through the Drugs Consultative Committee during its 67th meeting on November 17, 2025, followed by the Drugs Technical Advisory Board at its 93rd meeting on February 16, 2026. To accommodate current operators, existing licence holders will receive a transition window. The new rules will become mandatory only after the expiration of their current retention period or twelve months following the final gazette publication, whichever occurs later. The ministry has opened a 30-day window from the publication date of the draft rules for public and stakeholder feedback.

Key takeaways
  • Bulk drug wholesale will require new 19-BC application and 20-BC licence forms.
  • The Drugs Technical Advisory Board approved the proposal on February 16, 2026.
  • Stakeholders have 30 days to submit objections and suggestions after the draft gazette release.
How does this make you feel?
What is your view on this story?
Sign in to vote and see what other readers think.
The Times Reading dailyTop stories, markets and weather in one short email. Free, one-click unsubscribe.

Spotted an error? · Our editorial policy

UP NEXTSanjay Kapoor Stars in ‘Unexpected – Safed Sach’ Based on 2024 Dehradun CaseSwipe more stories · IndiaQuick cards, a few lines each. Tap to open.

More from India